‘The Biggest Biggest Problem’: New drug for Lyme disease can’t be patented
A new drug for treating Lyme disease has failed to make it to clinical trials.The National Institutes of Health said the drug, called BMS-8-D, is still in phase 3 clinical trials and was not approved by the US Food and Drug Administration for clinical use.The new drug is a joint effort between Pfizer and Sanofi […]
Read More